Omnicell, Inc. - Common Stock (NQ:OMCL)

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

Topics Firearms

AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards

April 07, 2026

Via Investor Brand Network

Topics Artificial Intelligence

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Topics Artificial Intelligence Government Stocks

Omnicell Inc (NASDAQ:OMCL) Stock Plummets on Earnings Miss and Soft 2026 Guidance ↗

February 05, 2026

Via Chartmill

Topics Earnings

AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards

April 07, 2026

From AINewsWire

Via GlobeNewswire

3 Cash-Heavy Stocks with Warning Signs

March 24, 2026

Over the past six months, Omnicell has been a great trade, beating the S&P 500 by 19.8%. Its stock price has climbed to $41.48, representing a healthy 26.4% ...

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

March 02, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Topics Stocks

3 Cash-Producing Stocks We Find Risky

February 25, 2026

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Omnicell’s fourth quarter was met with a significant negative market reaction, as the company delivered revenue in line with Wall Street expectations but posted a notable shortfall in non-GAAP...

Topics Economy Government World Trade

The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

February 12, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 2.3% year on year to $314 million. The company expects next quarter’s revenue to be...

Topics Earnings

OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

February 06, 2026

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 18.4% in the morning session after the company reported fourth-quarter earnings that fell short of Wall Street expectations and provided a...

Topics World Trade

Why Omnicell (OMCL) Shares Are Plunging Today

February 05, 2026

Omnicell (OMCL) Q4 2025 Earnings Call Transcript

Topics Artificial Intelligence

Omnicell (OMCL) Q4 2025 Earnings Call Transcript ↗

February 05, 2026

Via The Motley Fool

Topics Earnings World Trade

Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

February 05, 2026

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

February 05, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday before market hours. Here’s what investors should know.

Omnicell Earnings: What To Look For From OMCL

February 03, 2026

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) and...

Topics Artificial Intelligence

Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)

February 01, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but...

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

January 28, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Topics Stocks

3 Russell 2000 Stocks We Approach with Caution

January 25, 2026

The past six months have been a windfall for Omnicell’s shareholders. The company’s stock price has jumped 80.2%, hitting $50.52 per share. This was partly thanks to its solid quarterly results, and...

3 Reasons to Sell OMCL and 1 Stock to Buy Instead

January 19, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

3 Small-Cap Stocks We Keep Off Our Radar

January 15, 2026

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

January 13, 2026

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

3 Inflated Stocks with Open Questions

January 11, 2026

The stock has rallied significantly from its 52-week low of $22.66 in May.

Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs ↗

January 05, 2026

Via The Motley Fool

Topics Regulatory Compliance

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid

December 24, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management

December 08, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the...

1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off

December 07, 2025

Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show

Topics Stocks

December 01, 2025

Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz

November 25, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Privia Health (NASDAQ:PRVA) and its peers.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

3 Low-Volatility Stocks That Concern Us

November 25, 2025